Dermatopathology Laboratory. Pre-study lesion biopsy slides from patients in the screening phase will be sent to the central Dermatopathology laboratory for review and histological confirmation as part of the inclusion requirements. On Day 85 of the treatment the patient’s sBCC lesion will be excised and sent to a central dermatopathology laboratory for histological examination. In cooperation with Sponsor, Omnicare CR has identified a suitable lab, **** Estimated total pass-through costs have been added within the budget for PEP005-009. Omnicare CR will perform an assessment visit of this lab prior to project start, as further discussed under Section J. Clinical Quality Assurance, herein.
Appears in 4 contracts
Samples: Clinical Services Master Agreement (Peplin Inc), Clinical Services Master Agreement (Peplin Inc), Clinical Services Master Agreement (Peplin Inc)